Evoke Pharma Inc expected to post a loss of 8 cents a share - Earnings Preview

Evoke Pharma

02/08/2021 23:39

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a rise
in quarterly revenue when it reports results on August 4
(estimated). 
* The Solana Beach, California-based company is expected to
report revenue of $151 thousand, according to the estimate from
one analyst, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Evoke Pharma Inc is for
a loss of 8 cents per share. For the same quarter last year, the
company reported a loss of 28 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Evoke Pharma
Inc is $9​, about 87.3% above​ its last closing price
of $1.14. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.07       -0.06      -0.08     Missed  -23.1
 Dec. 31 2020  -0.07       -0.13      -0.09     Beat    33.3
 Sep. 30 2020  -0.07       -0.08      -0.08     Met     5.9​
 Jun. 30 2020  -0.08       -0.08      -0.28     Missed  -250
 Mar.          -0.05​      -0.05      -0.07     Missed  -40​
 31​ 2020​                                              
 Dec. 31 2019  -0.06       -0.06      -0.06     Met     0​
 Sep. 30 2019  -0.09       -0.09      -0.07     Beat    22.2
 Jun. 30 2019  -0.12       -0.12      -0.09     Beat    25
 This summary was machine generated August 2 at 22:39 GMT.  All
figures in US dollars unless otherwise stated